Sam Chun Dang Pharm Overview

  • Founded
  • 1943

Founded
  • Status
  • Public

  • Employees
  • 392

Employees
  • Stock Symbol
  • 000250

Stock Symbol
  • Investments
  • 1

  • Share Price
  • $25.35

  • (As of Tuesday Closing)

Sam Chun Dang Pharm General Information

Description

Samchundang Pharm Co Ltd is engaged in manufacturing, distributing, importing, and exporting pharmaceuticals in South Korea. The company offers ophthalmology, cardiovascular, endocrinology, antibacterial, anti-fungal, antiviral, respiratory, anti-inflammatory, antihistamine, and musculoskeletal products, as well as gastro intestines and vitamins.

Contact Information

Website
www.scd.co.kr
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Pharmaceuticals
Stock Exchange
KRX
Primary Office
  • 1606-1 Seocho-dong, Seocho-gu
  • Seoul, 137-877
  • South Korea
+82 00-0000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sam Chun Dang Pharm Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$25.35 $23.96 $23.43 - $56.03 $529M 22.1M 167K -$0.41

Sam Chun Dang Pharm Financials Summary

In Thousands,
USD
TTM 31-Mar-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 688,987 825,509 1,657,285 648,781
Revenue 145,158 146,038 141,325 160,026
EBITDA (3,652) (10,780) 18,865 21,090
Net Income (8,968) (14,453) (818) 8,963
Total Assets 298,578 289,027 290,653 250,486
Total Debt 59,636 43,311 24,818 20,592
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Sam Chun Dang Pharm Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sam Chun Dang Pharm‘s full profile, request access.

Request a free trial

Sam Chun Dang Pharm Patents

Sam Chun Dang Pharm Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2019517513-A Ophthalmic pharmaceutical composition Granted 26-Apr-2017 0000000000
JP-6677827-B2 Ophthalmic pharmaceutical composition Active 26-Apr-2017 0000000000
EP-3452075-B1 Ophthalmic pharmaceutical composition Active 26-Apr-2017 0000000000
US-20190160145-A1 Ophthalmic pharmaceutical composition Granted 26-Apr-2017 0000000000
EP-3452075-A1 Ophthalmic pharmaceutical composition Granted 26-Apr-2017 A61K38/179
To view Sam Chun Dang Pharm’s complete patent history, request access »

Sam Chun Dang Pharm Executive Team (3)

Name Title Board Seat Contact Info
Jeon-Kyo Park President & Chief Executive Officer
Jeon In-Seok Senior Managing Director
Kim Dae-Wook Senior Managing Director
To view Sam Chun Dang Pharm’s complete executive team members history, request access »

Sam Chun Dang Pharm Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sam Chun Dang Pharm Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000 00000 27-Dec-2012 0000000000 0000 Pharmaceuticals
To view Sam Chun Dang Pharm’s complete acquisitions history, request access »

Sam Chun Dang Pharm Subsidiaries (1)

Company Name Industry Location Founded
000 00000 Pharmaceuticals Seoul, South Korea 0000
To view Sam Chun Dang Pharm’s complete subsidiaries history, request access »